Potassium Carbonate → tert-butyl 4-(6-(6-(1-(cyclopropylmethyl)-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)-1,4-diazepane-1-carboxylate
반응식
[NH:1]1[CH:5]=[C:4]([C:6]2[N:11]=[CH:10][C:9]3[CH:12]=[N:13][N:14]([C:15]4[N:20]=[C:19]([N:21]5[CH2:27][CH2:26][CH2:25][N:24]([C:28]([O-:30])=[O:29])[CH2:23][CH2:22]5)[CH:18]=[CH:17][CH:16]=4)[C:8]=3[CH:7]=2)[CH:3]=[N:2]1.Br[CH2:32][CH:33]1[CH2:35][CH2:34]1.C([O-])([O-])=O.[K+].[K+]>CN(C=O)C>[CH:35]1([CH2:34][N:1]2[CH:5]=[C:4]([C:6]3[N:11]=[CH:10][C:9]4[CH:12]=[N:13][N:14]([C:15]5[N:20]=[C:19]([N:21]6[CH2:27][CH2:26][CH2:25][N:24]([C:28]([O:30][C:4]([CH3:6])([CH3:5])[CH3:3])=[O:29])[CH2:23][CH2:22]6)[CH:18]=[CH:17][CH:16]=5)[C:8]=4[CH:7]=3)[CH:3]=[N:2]2)[CH2:33][CH2:32]1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
A suspension of 4-(6-(6-(1H-pyrazol-4-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)-1,4-diazepane-1-carboxylate (200 mg, 0.43 mmol), (bromomethyl)cyclopropane (100 mg, 0.65 mmol), and K2CO3 (120 mg, 0.87 mmol) in DMF (10 mL) was stirred at room temperature for 18 hours. The reaction mixture was extracted with EtOAc (100 mL), washed with brine (50 mL), dried over MgSO4, and concentrated under reduced pressure. The crude was purified by silica gel chromatography using petroleum ether/EtOAc (2/1) as eluting solvents to afford tert-butyl 4-(6-(6-(1-(cyclopropylmethyl)-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)-1,4-diazepane-1-carboxylate as a white solid (200 mg, 89.6%). MS (ESI) m/z: 515 [M+H]+.
후처리
- extractionThe reaction mixture was extracted with EtOAc (100 mL)
- washwashed with brine (50 mL)
- dry with materialdried over MgSO4
- concentrationconcentrated under reduced pressure
- customThe crude was purified by silica gel chromatography
- washas eluting solvents
출처 및 근거
- ORD 기록
- ord-51ed50cc1eec435c8aaa8fa7eb0269fe
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09434725B2
반응 노트
불러오는 중…